AstraZeneca PLC
1258.50
09-April-25 05:36:41
15 minutes delayed
Stocks
-67.00
-5.05%
Today's range
1242.00 - 1281.50
ISIN
N/A
Source
Cboe
-
2 Healthcare Stocks That Tumbled in 2024...but Could See an Impressive Comeback in 2025
15 Feb 2025 09:07:29 By NASDAQ US Markets
-
AZN April 4th Options Begin Trading
13 Feb 2025 12:18:24 By NASDAQ US Markets
-
Why AstraZeneca Topped the Market on Thursday
06 Feb 2025 17:24:24 By NASDAQ US Markets
-
AstraZeneca Plc (AZN) Q4 2024 Earnings Call Transcript
06 Feb 2025 14:13:48 By NASDAQ US Markets
-
06 Feb 2025 10:38:48 By NASDAQ US Markets
-
AstraZeneca: CHMP Recommends Approval Of Imfinzi In The EU
03 Feb 2025 02:58:39 By NASDAQ US Markets
-
Interesting AZN Put And Call Options For March 14th
30 Jan 2025 11:09:34 By NASDAQ US Markets
-
FDA Approves AstraZeneca And Daiichi Sankyo's ENHERTU For HER2-Low/Ultralow Breast Cancer
27 Jan 2025 20:00:56 By NASDAQ US Markets
-
InnovationRx: The Impact Of Trump’s Withdrawal From The WHO And His Other Healthcare Orders
22 Jan 2025 13:41:38 By Forbes - World
-
FDA Okays AstraZeneca And Daiichi's Datroway For Metastatic HR-Positive, HER2-Negative Breast Cancer
18 Jan 2025 01:34:04 By NASDAQ US Markets
-
Better Buy: Novo Nordisk vs. AstraZeneca
04 Jan 2025 06:11:10 By NASDAQ US Markets
-
Syncona: Achilles Announces Sale Of Technology Assets To AstraZeneca - Quick Facts
27 Dec 2024 02:32:04 By NASDAQ US Markets
-
AstraZeneca And Daiichi Sankyo Withdraw EU Marketing Application For Datopotamab Deruxtecan
24 Dec 2024 02:40:25 By NASDAQ US Markets
-
22 Dec 2024 06:16:51 By NASDAQ US Markets
-
3 Unstoppable Stocks to Buy Right Now
15 Dec 2024 06:33:05 By NASDAQ US Markets
-
March 2025 Options Now Available For AstraZeneca (AZN)
06 Dec 2024 11:01:12 By NASDAQ US Markets
-
AZN : TROPION Analysis Reveals Datopotamab Deruxtecan Efficacy In Advanced EGFR-Mutated Lung Cancer
05 Dec 2024 22:31:29 By NASDAQ US Markets
-
FDA Approves AstraZeneca's Imfinzi For Limited-Stage Small Cell Lung Cancer
04 Dec 2024 21:59:20 By NASDAQ US Markets
-
AstraZeneca Names A MSK Leader To Global Cancer Post
25 Nov 2024 11:17:34 By Forbes - World
-
Lunit Collaborates With AstraZeneca To Develop AI-powered Digital Pathology Solutions
18 Nov 2024 13:17:39 By NASDAQ US Markets